Literature DB >> 18991870

Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury.

Hari Shanker Sharma1, Syed F Ali.   

Abstract

The psychostimulant 3,4-,ethylenedioxymethamphetamine (MDMA, "ecstasy") is known to induce hyperthermia and alterations in neurochemical metabolism in the CNS. However, the detailed cellular or molecular mechanisms behind MDMA-induced neurotoxicity are still not well known. Since MDMA induces profound hyperthermia that could lead to intense cellular stress and cause disruption of the blood-brain barrier (BBB), this investigation examined the effects of acute MDMA on BBB dysfunction, brain edema, and cell injury in rats and mice. When MDMA (40 mg/kg, i.p.) was administered to rats or mice, these animals exhibited profound behavioral disturbances (hyperactivity and hyperlocomotion) and hyperthermia (>40 to 41 degrees C) at 4 h. At this time, the leakage of Evans blue dye was evident, particularly in the cerebellum, hippocampus, cortex, thalamus, and hypothalamus. This effect was most pronounced in mice compared to rats. Marked increase in brain water along with Na(+), K(+), and Cl(-) content was also seen in the aforementioned brain regions. Presence of distorted neuronal and glial cells in brain regions associated with leakage of Evans blue is quite common in MDMA-treated animals. Increased albumin immunoreactivity, indicating breakdown of the BBB, and upregulation of glial fibrillary acidic protein (GFAP), suggesting activation of astrocytes, were seen in most brain regions showing edematous changes. Upregulation of heat-shock protein (HSP72) immunoreactivity in the nuclei and cell cytoplasm of the neurons located in the edematous brain regions are quite common. Taken together, these observations are the first to show that MDMA has the capacity to disrupt BBB permeability to proteins and to induce the formation of edema, probably by inducing hyperthermia and cellular stress, as evident with HSP overexpression leading to cell injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991870     DOI: 10.1196/annals.1432.052

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.

Authors:  Hector Rosas-Hernandez; Elvis Cuevas; Susan M Lantz; Kenner C Rice; Brenda M Gannon; William E Fantegrossi; Carmen Gonzalez; Merle G Paule; Syed F Ali
Journal:  Neurosci Lett       Date:  2016-06-16       Impact factor: 3.046

2.  Cardiac arrest-induced regional blood-brain barrier breakdown, edema formation and brain pathology: a light and electron microscopic study on a new model for neurodegeneration and neuroprotection in porcine brain.

Authors:  Hari Shanker Sharma; Adriana Miclescu; Lars Wiklund
Journal:  J Neural Transm (Vienna)       Date:  2010-10-21       Impact factor: 3.575

3.  Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA ("ecstasy") in Mice.

Authors:  Zeinab Ebrahimian; Zeinab Karimi; Mohammad Javad Khoshnoud; Mohammad Reza Namavar; Bahram Daraei; Mohsen Raza Haidari
Journal:  Innov Clin Neurosci       Date:  2017-02-01

4.  Hyperthermia increases interleukin-6 in mouse skeletal muscle.

Authors:  Steven S Welc; Neil A Phillips; Jose Oca-Cossio; Shannon M Wallet; Daniel L Chen; Thomas L Clanton
Journal:  Am J Physiol Cell Physiol       Date:  2012-06-06       Impact factor: 4.249

5.  Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use.

Authors:  Eugene A Kiyatkin; Albert H Kim; Ken T Wakabayashi; Michael H Baumann; Yavin Shaham
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

6.  MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI.

Authors:  J Rouine; O L Gobbo; M Campbell; V Gigliucci; I Ogden; K McHugh Smith; P Duffy; B Behan; D Byrne; M E Kelly; C W Blau; C M Kerskens; A Harkin
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity.

Authors:  Elisabet Cuyas; Patricia Robledo; Nieves Pizarro; Magí Farré; Elena Puerta; Norberto Aguirre; Rafael de la Torre
Journal:  Neurotox Res       Date:  2013-08-15       Impact factor: 3.911

8.  Effects of peripheral inflammation on the blood-spinal cord barrier.

Authors:  Dimitris N Xanthos; Isabella Püngel; Gabriele Wunderbaldinger; Jürgen Sandkühler
Journal:  Mol Pain       Date:  2012-06-18       Impact factor: 3.395

9.  Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction.

Authors:  P M Abdul Muneer; Saleena Alikunju; Adam M Szlachetka; L Charles Murrin; James Haorah
Journal:  Mol Neurodegener       Date:  2011-03-22       Impact factor: 14.195

10.  Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity.

Authors:  Elisa Torres; Maria D Gutierrez-Lopez; Andrea Mayado; Ana Rubio; Esther O'Shea; Maria I Colado
Journal:  J Neuroinflammation       Date:  2011-05-19       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.